Torrini I, Pagani Zecchini G, Paglialunga Paradisi M, Lucente G, Mastropietro G, Gavuzzo E, Mazza F, Pochetti G, Traniello S, Spisani S
Dipartimento di Studi Farmaceutici, Università La Sapienza, Roma, Italy.
Biopolymers. 1996 Sep;39(3):327-37. doi: 10.1002/(SICI)1097-0282(199609)39:3%3C327::AID-BIP5%3E3.0.CO;2-Q.
HCO-Thp-Ac6c-Phe-OMe (3) has been synthesized as a new analogue of the prototypical chemotactic agent HCO-Met-Leu-Phe-OMe (fMLP-OMe). Compound 3 contains 4-aminotetra-hydrothiopyran-4-carboxylic acid (Thp) and 1-aminocyclohexane-1-carboxylic acid (Ac6c) as achiral, conformationally restricted mimics of Met and Leu, respectively. In the crystal, the formyltripeptide adopts an helical conformation at the Thp and Ac6c residues, of the type alpha R and alpha L, respectively, whereas the C-terminal phenylalanine is quasi-extended. A system of two consecutive gamma-turns, centered at the first two residues, better explains the nmr data as compared with an alternative beta-turn structure. The conformation of the new analogue 3 is compared with those of two related peptides containing Thp as N-terminal residue. The biological activity of 3 has been determined on human neutrophils and compared to that of the previously studied model [Ac6c2] fMLP-OMe. While the above analogue is highly active in the superoxide anion production, the new tripeptide 3 is practically unable to elicit any of the tested biological activities.
